Nuofu Zhang to Disease Progression
This is a "connection" page, showing publications Nuofu Zhang has written about Disease Progression.
Connection Strength
0.028
-
Effect of Recombinant Human Granulocyte Colony-Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial. JAMA Intern Med. 2021 01 01; 181(1):71-78.
Score: 0.014
-
Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020 Jul; 146(1):89-100.
Score: 0.014